Login / Signup

Clinical Evaluation After Discontinuation of Galcanezumab in Japanese Patients with Episodic and Chronic Migraine: Analysis of a Randomized, Placebo-Controlled Trial and Open-label Extension Study.

Takao TakeshimaHikaru DoiSatomi OobaYuka TanjiAkichika OzekiMika Komori
Published in: Neurology and therapy (2024)
ClinicalTrials.gov, NCT02959177 and NCT02959190.
Keyphrases
  • clinical evaluation
  • open label
  • study protocol
  • clinical trial
  • double blind
  • squamous cell carcinoma
  • radiation therapy
  • phase ii study
  • drug induced